New combo therapy aims to stop lung cancer return after surgery
NCT ID NCT07353476
First seen Jan 20, 2026 · Last updated May 20, 2026 · Updated 19 times
Summary
This study is for people with stage III non-small cell lung cancer who had chemotherapy and immunotherapy before surgery, then surgery to remove the tumor, but still had cancer in their lymph nodes. Researchers want to see if adding targeted radiation to the lymph nodes after surgery, along with ongoing immunotherapy, can help keep the cancer from coming back better than immunotherapy alone. About 38 adults will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.